Lipid lowering and disturbances in platelet function and coagulation
How to optimize atherothromobotic therapies to reduce CVD risk
Riitta Lassila, Helsinki, Finland
Platelet activation and inhibition in dyslipidemias
Carlo Patrono, Rome, Italy
Atherosclerosis in ageing societies
How to optimize CVD risk reduction
Francesco Cosentino, Stockholm, Sweden
Primary prevention in ageing societies
Martin Mortensen, Aarhus, Denmark
Current insights into the role of gut microbiota in atherosclerosis
Is gut microbiota a risk factor for cardiovascular disease?
Christoph Reinhardt, Mainz, Germany
The impact of diet on gut microbiota in health and disease
Wendy Garrett, Massachusetts, USA
Liver as the center of lipid metabolism
NAFLD: a multisystem disease
Christopher D. Byrne, Southampton, United Kingdom
Triglyceride metabolism in the liver
David E. Cohen, New York, USA
Lymphatics, lipoproteins and the endothelium
Lymphatic system in cardiovascular medicine
Kari Alitalo, Helsinki, Finland
Lymphatics in the Regulation of Intestinal Lipid Mobilization
Gary Lewis, Toronto, Canada
